Results 81 to 90 of about 6,898 (170)

Nanoscaffold-based 3D human liver spheroids for predictive hepatotoxicity screening of antimalarial compounds from the global health priority box. [PDF]

Parasit Vectors
Wu L, Vllasaliu D, Mabayoje DA, Aspinall A, Raimi-Abraham BT.   +4 more
europepmc   +1 more source

Chemoproteomics-based profiling elucidates the antimalarial effects of amodiaquine through disruption of glycolysis process in Plasmodium falciparum. [PDF]

Cell Commun Signal
Wang J, Wang C, Zhuge R, Tang H, Xia F, Zhang Y, Zhang J, Liu C, Wu J, Chen X, Gao P, Wang J.   +11 more
europepmc   +1 more source

Emergence of Plasmodium falciparum pfdhps A581G mutation in Southern Senegal under Seasonal Malaria Chemoprevention pressure, 2020-2023. [PDF]

Commun Med (Lond)
Diallo MA, Tine A, Sow D, Sene A, Gaye A, Ndiaye YD, Gomis J, Dieye B, Deme AB, Yade MS, Ngom B, Garba MN, Ndiaye IM, Diongue K, Badiane AS, Seck MC, Ndiaye M, Ndiaye D.   +17 more
europepmc   +1 more source

Incidence and trends of adverse drug reactions during seasonal malaria chemoprevention among children: evidence from Ghana's pharmacovigilance database, 2015-2023. [PDF]

Malar J
Otoo BAF, Opoku-Mireku M, Seaneke SK, Darko DM, Sabblah GT, Bonful HA.   +5 more
europepmc   +1 more source

Fractional curative killing of pyronaridine or artesunate combinations with tafenoquine, 4-aminoquinolines, or azithromycin in a murine malaria-luciferase model. [PDF]

Antimicrob Agents Chemother
Lee G, Aneke JS, Sullivan DJ.
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023. [PDF]

Malar J
Koko VS, Skrip L, Kumeh O, Washington T, Diallo MO, Kafuko J, Inyang U, Ponce de León GF, Zhou Z, Laird VR, Zawolo J, Getahun B, Harmon-Gray WM, Plucinski M, Schultz JS.   +14 more
europepmc   +1 more source

Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2-11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial. [PDF]

Malar J
Hanson H, Marfo KS, Osei-Mensa J, Jaeger A, Sarpong N, Tsali DN, Martey A, Gyimah AK, Placca E, Oppong M, Foli G, Almoustapha NS, Amuasi J, May J, Maïga Ascofaré O.   +14 more
europepmc   +1 more source

Molecular markers of antimalarial drug resistance in pfk13, pfmdr1, pfdhfr, and pfdhps genes of Plasmodium falciparum in a rural municipality in Cubal, Benguela Province, Angola (2022-2023). [PDF]

Malar J
Mediavilla A, García X, Martínez-Vallejo P, Molina-de la Fuente I, Febrer-Sendra B, Silgado A, Francisco K, Maturana CR, Martins JF, Nindia A, Martínez-Campreciós J, Aznar ML, Oliveira-Souto I, Molina I, Sulleiro E, Berzosa P.   +15 more
europepmc   +1 more source

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source

Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in <i>Plasmodium berghei</i>-infected mice. [PDF]

Toxicol Rep
Olanlokun JO, Yahaya OO, Babarinde CO, Oloke OM, Steenkamp P, Prinsloo G.   +5 more
europepmc   +1 more source